503B: A Quick-Guide to Compounding Pharmacy Designations & Regulations, accessed December 19, 2025, Conducting a Biopharmaceutical Freedom-to-Operate (FTO) Analysis: Strategies for Efficient and Robust Results DrugPatentWatch, accessed December 19, 2025, The Viability of a Compounding Pharmacy Patent Exception in the United States, accessed December 19, 2025, Compounding Pharmacies and Drug Patents: Navigating a Complex Relationship for Competitive Advantage DrugPatentWatch, accessed December 19, 2025, Compounded Drug Products That Are Essentially Copies of Approved Drug Products Under Section 503B of the Federal Food, Drug, and Cosmetic Act Guidance for Industry | FDA, accessed December 19, 2025, FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize, accessed December 19, 2025, Patenting Privation (Part III): Empowering Revenge Above the Law, accessed December 19, 2025, Compounding when Drugs are on FDAs Drug Shortages List, accessed December 19, 2025, Intellectual Property Challenges for 503A Pharmacy Compounding Frier Levitt, accessed December 19, 2025, Compounding Inequities Through Drug IP and Unfair Competition Scholarship @ GEORGETOWN LAW, accessed December 19, 2025, Conducting a Biopharmaceutical Freedom-to-Operate (FTO) Analysis: Key Considerations for Generic Drug Stability Testing DrugPatentWatch Transform Data into Market Domination, accessed December 19, 2025, Sharpening a biotech patent through methods claims under the litigation strategy of induced infringement: A message from the US Federal Circuit full court decision NIH, accessed December 19, 2025, Novo Nordisk v

This approach preserves sensitivity and reduces total peptide load over time
Document review Request current COA, HPLC chromatogram, MS identity support, SDS, storage notes, sequence context, salt or counter-ion notes when disclosed, and batch-specific label details
This could be why the HHS got involved when Stuart referred Hims to the DOJ
Legitimate peptide therapies [like a GLP-1], intended for human use, require medical oversight, and must be dispensed through licensed pharmacies